Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor

Ítems similars

• Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin
  per: Dingemanse, J, et al.
  Publicat: (2002)
• Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
  per: Dingemanse, Jasper, et al.
  Publicat: (2002)
• Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
  per: Sidharta, P. N., et al.
  Publicat: (2015)
• Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
  per: Bruderer, Shirin, et al.
  Publicat: (2011)
• Macitentan: entry-into-humans study with a new endothelin receptor antagonist
  per: Sidharta, Patricia N., et al.
  Publicat: (2011)